| P2093 | author name string | Andres M Kanner | |
| | Ramses Ribot | |
| P2860 | cites work | Increased levels of glutamate in brains from patients with mood disorders. | Q48133783 |
| | Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression | Q48208784 |
| | Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state | Q48248541 |
| | Anxiolytic effects of rapid amygdala kindling, and the influence of early life experience in rats | Q48283971 |
| | Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects | Q48316252 |
| | Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats | Q48326165 |
| | Early postnatal stress confers enduring vulnerability to limbic epileptogenesis | Q48375594 |
| | Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials. | Q48456999 |
| | The IL-1beta system in epilepsy-associated malformations of cortical development | Q48464931 |
| | Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats | Q48554057 |
| | Epilepsy, suicidality, and psychiatric disorders: a bidirectional association | Q48628471 |
| | Postnatal epigenetic influences on seizure susceptibility in seizure-prone versus seizure-resistant rat strains | Q48682883 |
| | Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone | Q48809728 |
| | Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients | Q49043310 |
| | Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. | Q51980100 |
| | CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa | Q70858241 |
| | Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys | Q71498504 |
| | Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon | Q71611825 |
| | Major depression is a risk factor for seizures in older adults | Q73425521 |
| | Mood disorders and medical illness: a major public health problem | Q73739199 |
| | Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex | Q79904382 |
| | Correlation between plasma levels of glutamate, alanine and serine with severity of depression | Q83364115 |
| | Sound-induced seizures in serotonin 5-HT2c receptor mutant mice | Q24320030 |
| | ILAE official report: a practical clinical definition of epilepsy | Q27009103 |
| | Biomarkers of epileptogenesis: psychiatric comorbidities (?) | Q27015612 |
| | Antidepressant effects of ketamine in depressed patients | Q29617327 |
| | A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression | Q29617914 |
| | Further evidence of anticonvulsant role for 5‐hydroxytryptamine in genetically epilepsy‐prone rats | Q30498788 |
| | Beyond monoamines: glutamatergic function in mood disorders | Q33231128 |
| | Major depression and activation of the inflammatory response system | Q33708105 |
| | Increased cerebrospinal fluid glutamine levels in depressed patients | Q33896467 |
| | Glial cell abnormalities in major psychiatric disorders: the evidence and implications | Q34384584 |
| | Impact of corticosterone treatment on spontaneous seizure frequency and epileptiform activity in mice with chronic epilepsy | Q34430688 |
| | An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. | Q34881233 |
| | Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights | Q35225697 |
| | Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice | Q35314740 |
| | Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice | Q35989109 |
| | Glial reduction in the subgenual prefrontal cortex in mood disorders | Q36651128 |
| | Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine | Q36983761 |
| | The role of cytokines in the pathophysiology of epilepsy | Q37169936 |
| | Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? | Q38047583 |
| | Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs? | Q38080304 |
| | Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery. | Q38853667 |
| | Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis | Q38939651 |
| | Effects of several centrally active drugs on the sleep-wakefulness cycle of cats | Q39249746 |
| | Predictors of pharmacoresistant epilepsy | Q40194333 |
| | Noradrenergic abnormalities in the genetically epilepsy-prone rat. | Q40595175 |
| | Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis | Q42526811 |
| | Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder | Q43890441 |
| | Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors | Q43941593 |
| | Increased cortical GABA concentrations in depressed patients receiving ECT. | Q44336422 |
| | Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus | Q44606921 |
| | Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors | Q44893909 |
| | Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression | Q44966221 |
| | Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE. | Q46381650 |
| | 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats | Q46579698 |
| | Depression and suicide attempt as risk factors for incident unprovoked seizures | Q46746287 |
| | Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation | Q46893789 |
| | Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. | Q47191236 |
| | Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE. | Q47710098 |
| | The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors | Q48114052 |
| P433 | issue | Pt B | |
| P921 | main subject | mood disorder | Q188638 |
| P304 | page(s) | 298-301 | |
| P577 | publication date | 2019-06-08 | |
| P1433 | published in | Epilepsy Behavior | Q15746410 |
| P1476 | title | Neurobiologic properties of mood disorders may have an impact on epilepsy: Should this motivate neurologists to screen for this psychiatric comorbidity in these patients? | |
| P478 | volume | 98 | |